Skip to main content
SpringerLink
Log in

Some prescription drugs may be a stumbling block to the exercise performance of elite athletes

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I

References

  1. Alaranta A, Alaranta H, Helenius I. Use of prescription drugs in athletes. Sports Med 2008; 38(6): 449–63

    Article  PubMed  Google Scholar 

  2. Alaranta A, Alaranta H, Heliövaara M, et al. Ample use of medications in elite athletes. Int J Sports Med 2006; 27(11): 919–25

    Article  PubMed  CAS  Google Scholar 

  3. Huang S-H, Johnson K, Pipe AL. The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic games. Clin J Sport Med 2006; 16(1): 27–33

    Article  PubMed  Google Scholar 

  4. Corrigan B, Kazlauskas R. Medication use in athletes selected for doping control at the Sydney Olympics (2000). Clin J Sports Med 2003; 13(1): 33–40

    Article  Google Scholar 

  5. Moore RA, Tramer MR, Carroll D, et al. Quantitative systemic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998; 316(7128): 333–8

    Article  PubMed  CAS  Google Scholar 

  6. Trappe TA, White F, Lambert CP, et al. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab 2002; 282(3): E551–6

    PubMed  CAS  Google Scholar 

  7. Reynolds JF, Noakes T, Schwellnus MP, et al. Nonsteroidal anti-inflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy. S Afr Med J 1995; 85(6): 517–22

    PubMed  CAS  Google Scholar 

  8. Mazieres B, Rouanet S, Velicy J, et al. Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study. Am J Sports Med 2005 Apr; 33(4): 515–23

    Google Scholar 

  9. Walker RJ, Fawcett JP, Flannery EM, et al. Indomethacin potentiates exercise induced reduction in renal hemodynamics in athletes. Med Sci Sports Exerc 1994; 26(11): 1302–6

    PubMed  CAS  Google Scholar 

  10. Anderson SD, Sue-Chu M, Perry CP, et al. Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 Summer Olympics. J Allergy Clin Immunol 2006 Apr; 117(4): 767–73

    Article  PubMed  CAS  Google Scholar 

  11. Kindermann W. Do inhaled β2-agonists have an ergogenic potential in non-asthmatic competitive athletes? Sports Med 2007; 37(2): 95–102

    Article  PubMed  Google Scholar 

  12. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British national formulary. No. 56. London: BMJ Publishing Group Ltd and RPS Publishing, 2008 Sep

    Google Scholar 

  13. Sue-Chu M, Sandsund M, Holand B, et al. Montelukast does not affect exercise performance at subfreezing temperature in highly trained non asthmatic endurance athletes. Int J Sports Med 2000; 21(6): 424–8

    Article  PubMed  CAS  Google Scholar 

  14. Spooner C, Rowe BH, Saunders LD. Nedcromil sodium in the treatment of exercise-induced asthma: a meta-analysis. Eur Respir J 2000; 16(1): 30–7

    Article  PubMed  CAS  Google Scholar 

  15. Spooner CH, Spooner GR, Rowe BH. Mast-cell stabilizing agents to prevent exercise-induced bronchoconstriction. Cochrane Database Syst Rev 2003; (4): CD002307

  16. Katelaris CH, Carrozzi FM, Burke TV. Allergic rhinoconjunctivitis in elite athletes: optimal management for quality of life and performance. Sports Med 2003; 33(6): 401–6

    Article  PubMed  Google Scholar 

  17. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systemic review of randomised controlled trials. BMJ 1998; 317(7173): 1624–9

    Article  PubMed  CAS  Google Scholar 

  18. Carrozzi FM, Katelaris CH, Burke TV, et al. An open study examining the effects of intranasal budesonide on quality of life and performance in elite athletes with allergic rhinoconjunctivitis [abstract]. J Allergy Clin Immunol 2001; 107: S154–5

    Google Scholar 

  19. Hodges K, Hancock S, Currell K, et al. Pseudoephedrine enhances performance in 1500-m runners. Med Sci Sports Exerc 2006 Feb; 38(2): 329–33

    Article  PubMed  Google Scholar 

  20. Bents RT, Tokish JM, Goldberg L. Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players. Phys Sportsmed 2004; 32(1): 30–4

    PubMed  Google Scholar 

  21. Ciocca M. Medication and supplement use by athletes. Clin Sports Med 2005 Jul; 24(3): 719–38, x-xi

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Some prescription drugs may be a stumbling block to the exercise performance of elite athletes. Drugs Ther. Perspect 25, 23–26 (2009). https://doi.org/10.2165/0042310-200925040-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/0042310-200925040-00008

Search

Navigation